A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC).

Liver enzymes are proteins in your liver that speed up chemical reactions. If your liver is damaged, blood tests will show abnormally high levels of these enzymes circulating in your bloodstream.

Dynamic angiogenic switch as predictor of response to chemotherapy+ bevacizumab in patients with metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I.

DURHAM, N.C. – A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to doctors at Duke Cancer ...

Patients with paroxysmal nocturnal hemoglobinuria (PNH) had decreased quality of life (QOL) and worse fatigue that could be linked to lactate dehydrogenase levels. Researchers found that levels of ...